M&A Deal Summary |
|
|---|---|
| Date | 2020-05-21 |
| Target | Teva Takeda Pharma - Clinical Packaging Facility |
| Sector | Life Science |
| Buyer(s) | Catalent |
| Sellers(s) | Teva Takeda Pharma |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2007 |
| Sector | Life Science |
| Revenue | 4.3B USD (2023) |
Catalent is a provider of solutions for drugs, biologics and consumer health products. Among its core offerings, it develops and manufactures oral and sterile medication in nearly all dosage forms, holds patents for softgel (e.g. “Liqui-Caps” and “Vegicaps”) and Zydis fast-dissolve technologies used in many popular prescription and over-the-counter medicine. Catalent was founded in 2007 and is based in Somerset, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 16 |
| Sector: Life Science M&A | 7 of 10 |
| Type: Divestiture M&A Deals | 3 of 6 |
| Country: Japan M&A | 1 of 1 |
| Year: 2020 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-02-03 |
MaSTherCell SA
Gosselies, Belgium MaSTherCell SA (Manufacturing Synergies for Therapeutic Cells) is a technology-driven, customer-oriented Contract Development and Manufacturing Organization (CDMO) specialized in cell therapy development for advanced medicinal products. MaSTherCell was established in 2011 and is based in Gosselies, Belgium. |
Buy | $315M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-10-29 |
Skeletal Cell Therapy Support SA
Charleroi, Belgium Skeletal Cell Therapy Support SA owns and operates a purpose-built CGxP facility of approximately 41,000 square-foot (3,800 square-meter), including its related quality control and product development laboratories, warehouse, grade C, and B cleanrooms and equipment as well as land for further development. Skeletal Cell Therapy Support is based in Charleroi, Belgium. |
Buy | €12M |
Teva Takeda Pharma Ltd. is a pharmaceutical company that provides generic drugs and off-patent drugs (OPD: drugs whose patent period has expired), which are long-listed products.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Japan M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
